icans
Showing 26 - 50 of 273
Immune Effector Cell-Associated Neurotoxicity Syndrome
Not yet recruiting
- Immune Effector Cell Associated Neurotoxicity Syndrome
- (no location specified)
Dec 1, 2022
Metastatic Colorectal Cancer Trial in France (Regorafenib then Trifluridine/Tipiracil, Trifluridine/Tipiracil then Regorafenib)
Recruiting
- Metastatic Colorectal Cancer
- Regorafenib then Trifluridine/Tipiracil
- Trifluridine/Tipiracil then Regorafenib
-
Bouge, Belgium
- +37 more
Dec 14, 2022
Ovarian Carcinosarcoma, Endometrial Carcinosarcoma Trial in France (Niraparib, Niraparib + TSR-042 (Dostarlimab), Chemotherapy
Recruiting
- Ovarian Carcinosarcoma
- Endometrial Carcinosarcoma
- Niraparib
- +2 more
-
Angers, France
- +19 more
Feb 23, 2022
HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma Trial in France, Spain, United
Recruiting
- HPV-Related Carcinoma
- +4 more
- TG4001
- Avelumab
-
Jacksonville, Florida
- +16 more
Feb 14, 2022
Hematopathology Eligible or CAR-t Cell Treatment Trial in France
Recruiting
- Hematopathology Eligible or CAR-t Cell Treatment
-
Amiens, France
- +35 more
Aug 22, 2022
Lung Cancer Metastatic, Renal Cell Carcinoma, Head Neck Cancer Trial in France (Reduced dose intensity of IO)
Recruiting
- Lung Cancer Metastatic
- +7 more
- Reduced dose intensity of IO
-
Angers, France
- +25 more
Jun 24, 2022
Non Small Cell Lung Cancer Metastatic Trial in Worldwide (GEN1046, Pembrolizumab)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- GEN1046
- Pembrolizumab
-
Santa Rosa, California
- +26 more
Jan 30, 2023
Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)
Recruiting
- Non-Hodgkin Lymphoma
- Biospecimen Collection
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jan 13, 2023
Digestive System Disease, Tumors Trial in Strasbourg (EPODIG-G program (coordination of supportive care))
Recruiting
- Digestive System Disease
- Neoplasms
- EPODIG-G program (coordination of supportive care)
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Nov 23, 2022
Serum Neurofilament Light asMarker for Brain Injury in
Recruiting
- Neurotoxicity
-
Saint Louis, MissouriWashington University School of Medicine
Oct 10, 2022
Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])
Recruiting
- Platinum-sensitive Ovarian Cancer
- Relapsed Ovarian Cancer
- OSE2101
- Pembrolizumab 25 MG/ML [Keytruda]
-
Angers, France
- +27 more
Jul 25, 2022
Endometrial Cancer Trial in France (Carboplatin-Paclitaxel, Dostarlimab)
Recruiting
- Endometrial Cancer
-
Angers, France
- +40 more
Aug 9, 2022
Solid Tumor Trial in United Kingdom, United States (Farletuzumab ecteribulin)
Recruiting
- Solid Tumor
- Farletuzumab ecteribulin
-
Tucson, Arizona
- +26 more
Jan 30, 2023
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial
Not yet recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +5 more
- Interferon Beta-1A
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
Cabozantinib in Combination With Nivolumab as First-line
Recruiting
- Advanced Renal Cell Carcinoma
-
Angers, France
- +42 more
Dec 1, 2022
Acute Myeloid Leukemia, Myeloproliferative Syndrome Trial in France (CPX-351)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloproliferative Syndrome
-
Amiens, France
- +33 more
Feb 7, 2022
Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem
Not yet recruiting
- Hematologic Malignancy
- +5 more
- autologous hematopoietic stem cells added to planned CAR T
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 31, 2023
Breast Cancer Stage II Trial in France, Portugal, Spain (Ribociclib (neoadjuvant), Chemotherapy (adjuvant), Ribociclib
Recruiting
- Breast Cancer Stage II
- Ribociclib (neoadjuvant)
- +2 more
-
Avignon, France
- +49 more
Jul 7, 2022
CLL/SLL Trial in France (First line therapy)
Not yet recruiting
- CLL/SLL
- First line therapy
-
Amiens, France
- +57 more
Oct 21, 2022
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +38 more
Jan 25, 2023
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +37 more
Jan 25, 2023
Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)
Not yet recruiting
- Head and Neck Cancer
- +3 more
- Cyclophosphamide
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 18, 2023